These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19475840)

  • 1. [Dilated cardiomyopathy post-chemotherapy].
    Sbrana F; Greco P; Rovai D
    Recenti Prog Med; 2009 Mar; 100(3):132-6. PubMed ID: 19475840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitor for epirubicin-induced dilated cardiomyopathy.
    Hatake K; Miura Y
    Lancet; 1996 May; 347(9013):1485. PubMed ID: 8676653
    [No Abstract]   [Full Text] [Related]  

  • 3. Left ventricular function in patients with toxic cardiomyopathy and with idiopathic dilated cardiomyopathy treated with Doxorubicin.
    Katamadze NA; Lartsuliani KP; Kiknadze MP
    Georgian Med News; 2009 Jan; (166):43-8. PubMed ID: 19202217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anthracycline-induced cardiomyopathy].
    Roul G; Cohen C; Lieber A
    Presse Med; 2009 Jun; 38(6):987-94. PubMed ID: 19423276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilated cardiomyopathy in a pregnant woman after doxorubicin and radiotherapy for Hodgkin's disease: a case report.
    Hadar A; Sheiner E; Press F; Katz A; Katz M
    J Reprod Med; 2004 May; 49(5):401-3. PubMed ID: 15214719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
    Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
    J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of anthracycline-induced dilated cardiomyopathy due to mutation on LMNA gene in a breast cancer patient: a case report.
    Kuruc JC; Durant-Archibold AA; Motta J; Rao KS; Trachtenberg B; Ramos C; Wang H; Gorenstein D; Vannberg F; Jordan K
    BMC Cardiovasc Disord; 2019 Jul; 19(1):169. PubMed ID: 31311496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?
    van den Berg MP; van Spaendonck-Zwarts KY; van Veldhuisen DJ; Gietema JA; Postma A; van Tintelen JP
    Eur J Heart Fail; 2010 Dec; 12(12):1297-9. PubMed ID: 20952769
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A heart transplant in a patient with doxorubicin-induced myocardiopathy as a complication of the treatment of a lymphoma].
    Rubio JA; Pulpón LA; Cavero MA; Oteo JF; Maicas C; Silva L; Serrano-Fiz S; Burgos R; Artaza M; Téllez G
    Rev Esp Cardiol; 1994 Nov; 47(11):777-9. PubMed ID: 7800910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of normalized left ventricular systolic function after discontinuation of treatment in patients with dilated cardiomyopathy.
    Alahakoon PT; Binkley PF
    Congest Heart Fail; 2009; 15(5):245-6. PubMed ID: 19751427
    [No Abstract]   [Full Text] [Related]  

  • 12. Left ventricular aneurysm in a patient with Duchenne muscular dystrophy.
    Fayssoil A; Abdallah C; Orlikowski D
    Presse Med; 2014 Jun; 43(6 Pt 1):731-2. PubMed ID: 24525307
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibilities of testosterone in complex therapy of patients with dilated cardiomyopathy].
    Kurbanov RD; Abdullaev TA; Mardanov BU
    Kardiologiia; 2009; 49(12):50. PubMed ID: 20038282
    [No Abstract]   [Full Text] [Related]  

  • 15. Dilated cardiomyopathy : clinical profile and treatment.
    Khalil A; Chawla K; Chakravarti A
    Indian Pediatr; 2000 Nov; 37(11):1242-6. PubMed ID: 11086307
    [No Abstract]   [Full Text] [Related]  

  • 16. Case of the month. Idiopathic dilated cardiomyopathy.
    Parker T
    JAAPA; 2009 Jul; 22(7):70. PubMed ID: 19697577
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversible dilated cardiomyopathy in a patient with Cushing's syndrome.
    Yong TY; Li JY
    Congest Heart Fail; 2010; 16(2):77-9. PubMed ID: 20412474
    [No Abstract]   [Full Text] [Related]  

  • 18. [The feature of cardial remodeling process at Doxorubicin chemotherapy and idiopathic dilatative cardiomyopathy].
    Katamadze NA; Lartsuliani KP; Begishvili NN; Dundua KhV; Kiknadze MP
    Georgian Med News; 2006 Jan; (130):61-4. PubMed ID: 16510915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological left ventricular reverse remodeling in elderly patients receiving optimal therapy for chronic heart failure.
    Cioffi G; Tarantini L; De Feo S; Pulignano G; Del Sindaco D; Stefenelli C; Opasich C
    Eur J Heart Fail; 2005 Oct; 7(6):1040-8. PubMed ID: 16227142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peculiarities of cardiac failure treatment in diffuse myocarditis and dilated cardiomyopathy].
    Gurevich MA; Iankovskaia MO; Gordienko BV; Mravian SR; Grigor'eva NM
    Klin Med (Mosk); 1997; 75(1):48-50. PubMed ID: 9082062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.